Galapagos NV (GLPG)

45.53
-0.47(-1.02%)
  • Volume:
    251,594
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    45.49 - 46.45

GLPG Overview

Prev. Close
46
Day's Range
45.49-46.45
Revenue
582.92M
Open
45.85
52 wk Range
45.3-127.7
EPS
-3.42
Volume
251,594
Market Cap
2.98B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
404,351
P/E Ratio
-
Beta
0.68
1-Year Change
-61.51%
Shares Outstanding
65,530,121
Next Earnings Date
04 Nov 2021
What is your sentiment on Galapagos NV?
or
Market is currently closed. Voting is open during market hours.

Galapagos NV News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell

Galapagos NV Company Profile

Galapagos NV Company Profile

Employees
1397

Galapagos NV is a Belgium-based clinical-stage biotechnology company. The Company is focused on the discovery and development of small molecule medicines with novel modes of action. Its pipeline comprises Phase 3, 2, 1, pre-clinical studies and discovery small-molecule and antibody programs in cystic fibrosis, inflammation, and other indications. The Company aims to develop a portfolio of clinical-stage therapies for the enhancement of existing treatment paradigms. In addition, the Company’s mission is to develop a number of medicines based on the discovery of novel targets. Galapagos NV also discovers which proteins that are involved in causing diseases such as, rheumatoid, arthritis, inflammatory bowel disease and fibrosis. Galapagos aims to develop small molecules that inhibit these targets, restore the balance and thereby positively influence the course of the disease.

Read More
  • 💩
    0
    • time to replace mgmt by some more competent people? looks like they lost it and can not get a grip anymore????what failure is next in the pipeline?!
      0
      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.